BGI Genomics Co Ltd (300676) — Cash Flow Quality Index
BGI Genomics Co Ltd (300676) has a Cash Flow Quality Index of -0.29x as of June 2025. Operating cash flow of CN¥-16.74 Million is below net income of CN¥58.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can BGI Genomics Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BGI Genomics Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for BGI Genomics Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of BGI Genomics Co Ltd.
Annual Cash Flow Quality Index for BGI Genomics Co Ltd (2012–2023)
Year-by-year earnings quality comparison for BGI Genomics Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 4.40x | CN¥408.77 Million | CN¥92.90 Million | ▲ +2598.8% |
| 2022 | 0.16x | CN¥130.88 Million | CN¥802.77 Million | ▼ -90.4% |
| 2021 | 1.69x | CN¥2.48 Billion | CN¥1.46 Billion | ▼ -1.1% |
| 2020 | 1.71x | CN¥3.60 Billion | CN¥2.10 Billion | ▲ +111.2% |
| 2019 | 0.81x | CN¥224.25 Million | CN¥276.33 Million | ▲ +2036.4% |
| 2018 | 0.04x | CN¥14.69 Million | CN¥386.65 Million | ▼ -93.8% |
| 2017 | 0.61x | CN¥243.66 Million | CN¥398.09 Million | ▼ -13.0% |
| 2016 | 0.70x | CN¥234.07 Million | CN¥332.69 Million | ▼ -43.9% |
| 2015 | 1.25x | CN¥328.68 Million | CN¥262.10 Million | ▲ +999.0% |
| 2014 | -0.14x | CN¥-8.16 Million | CN¥58.53 Million | ▼ -165.6% |
| 2013 | 0.21x | CN¥36.70 Million | CN¥172.67 Million | ▼ -75.0% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥85.35 Million | — |